Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer

J Clin Oncol. 2004 Nov 15;22(22):4646-8. doi: 10.1200/JCO.2004.02.168.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Epidermal Growth Factor / antagonists & inhibitors
  • Female
  • Gefitinib
  • Humans
  • Hyperpigmentation / chemically induced*
  • Lung Neoplasms / drug therapy
  • Middle Aged
  • Paronychia / chemically induced*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Epidermal Growth Factor
  • Protein-Tyrosine Kinases
  • Gefitinib